<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="2 (SARS-CoV-2), causes a pathogenic condition that has been termed" exact="coronavirus disease 2019" post="(COVID-19) and has reached pandemic proportions. As of 17"/>
 <result pre="more than 1 million lives worldwide. Accumulating evidence suggests that" exact="SARS-CoV-2 infection" post="can lead to a variety of clinical conditions, ranging"/>
 <result pre="ill patients subsequently die. Insights into the pathogenic mechanisms underlying" exact="SARS-CoV-2 infection" post="and COVID-19 progression are emerging and highlight the critical"/>
 <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the progression of" exact="coronavirus disease 2019" post="(COVID-19), focusing on the immunological hyper-response and the induction"/>
 <result pre="the expense of effective adaptive immunity, underpins the progression of" exact="coronavirus disease 2019" post="(COVID-19). In severe cases of COVID-19, massive endothelial dysfunction,"/>
 <result pre="epidemic diseases in humans: severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS) in 2003 and 2012, respectively. Severe acute respiratory"/>
 <result pre="Middle East respiratory syndrome (MERS) in 2003 and 2012, respectively." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is a novel coronavirus that was"/>
 <result pre="of 17 September 2020, the disease caused by SARS-CoV-2, named" exact="coronavirus disease 2019" post="(COVID-19), has reached pandemic proportions, affecting more than 30"/>
 <result pre="1 SARS-CoV-2 structure, genome composition and life cycle. a |" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is a typical betacoronavirus belonging the"/>
 <result pre="proteins, as well as several accessory proteins with unknown functions1,6." exact="SARS-CoV-2 infection" post="(Fig.Â 1c) begins when the viral spike protein attaches"/>
 <result pre="review the current understanding of the pathogenic mechanisms involved in" exact="SARS-CoV-2 infection" post="and progression of COVID-19, focusing on the critical role"/>
 <result pre="also examine emerging data in support of a role for" exact="SARS-CoV-2 infection" post="in inducing widespread endothelial damage, complement-associated blood clotting and"/>
 <result pre="that may be repurposed to treat severe cases of COVID-19." exact="SARS-CoV-2 infection" post="and COVID-19 The human-to-human transmission of SARS-CoV-2 is primarily"/>
 <result pre="targets17,18, owing to their substantial expression of ACE2 and TMPRSS2." exact="SARS-CoV-2 infection" post="induces these epithelial cells to undergo apoptotic cell death"/>
 <result pre="Kidneys, brain, heart, eye and gut can be affected by" exact="SARS-CoV-2 infection," post="potentially leading to specific disease manifestations such as anosmia"/>
 <result pre="evidence suggests that a suboptimal or unrestrained immune response during" exact="SARS-CoV-2 infection" post="drives the clinical patterns, disease severity and progression of"/>
 <result pre="viral eradication and resolution of the disease. In these patients," exact="coronavirus disease 2019" post="(COVID-19) seems to manifest as a mild disease with"/>
 <result pre="possibly individual predisposition or differences in viral loads during primary" exact="SARS-CoV-2 infection," post="some patients experience more severe disease. A maladaptive immune"/>
 <result pre="its translocation and IFN-I activation50. In support of this hypothesis," exact="SARS-CoV-2 infection" post="is associated with lower IFN-I and IFN-III levels and"/>
 <result pre="syndrome, secondary haemophagocytic lymphohistiocytosis, and consequently, the immune response to" exact="SARS-CoV-2 infection" post="was initially considered to involve a form of cytokine"/>
 <result pre="non-infected macrophages61. Moreover, use of untargeted metabolomics has shown that" exact="SARS-CoV-2 infection" post="triggers profound alterations in macrophage phenotype and function by"/>
 <result pre="lavage fluid cells from eight patients with COVID-19 suggested that" exact="SARS-CoV-2 infection" post="elicits more pronounced neutrophil infiltration than other forms of"/>
 <result pre="suggest that the rise in inflammatory cytokine levels induced by" exact="SARS-CoV-2 infection" post="might drive the depletion of T and NK cells,"/>
 <result pre="shown in a preprint study, longitudinal evaluation of patients with" exact="SARS-CoV-2 infection" post="reported a rapid decline in levels of neutralizing antibody"/>
 <result pre="SARS-CoV-2. In support of a dysregulated B cell response to" exact="SARS-CoV-2 infection," post="analyses of circulating B cells showed expansion of oligoclonal"/>
 <result pre="and adaptive immunity, including the cellular and humoral response to" exact="SARS-CoV-2 infection" post="(Fig.Â 2). These findings indicate the need for further"/>
 <result pre="suggested that children may be at a lower risk of" exact="SARS-CoV-2 infection" post="than adults owing to the lower expression of ACE2"/>
 <result pre="as a result of the severe inflammatory state caused by" exact="SARS-CoV-2 infection;" post="none of these children had underlying cardiovascular disease122. SARS-CoV-2"/>
 <result pre="reduction of ACE2 expression by endothelial cells in response to" exact="SARS-CoV-2 infection" post="leads to reduced generation of Ang 1â€&quot;7 and consequently,"/>
 <result pre="as reported by a preprint study135. Fig. 3 Effect of" exact="SARS-CoV-2 infection" post="on endothelial cell function, systemic coagulation and thrombosis. a"/>
 <result pre="on endothelial cell function, systemic coagulation and thrombosis. a |" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) directly infects endothelial cells owing to"/>
 <result pre="unrestrained activation â€&quot; for example, in the context of prolonged" exact="SARS-CoV-2 infection" post="â€&quot; can be detrimental by causing direct damage of"/>
 <result pre="can activate C1 and initiate complement activation. In patients with" exact="SARS-CoV infection," post="the development of autoantibodies against human pulmonary epithelial cells"/>
 <result pre="complement-dependent cytotoxicity143; however, whether this process is also activated following" exact="SARS-CoV-2 infection" post="is unknown. Use of an ultra-high-throughput clinical proteomic approach"/>
 <result pre="Findings from another study suggest that enhanced IgA levels during" exact="SARS-CoV-2 infection" post="might act synergistically with IgG to promote antibody-dependent cytotoxicity108."/>
 <result pre="classical pathway-mediated cytotoxicity. Although clinical insights into complement activation following" exact="SARS-CoV-2 infection" post="are limited145, the above findings indicate that unrestrained complement"/>
 <result pre="important role in outcomes following SARS-CoV-2 infection148. Indeed, patients with" exact="SARS-CoV-2 infection" post="are at an increased risk of widespread coagulation of"/>
 <result pre="involvement in COVID-19 The lungs are the main site for" exact="SARS-CoV-2 infection" post="and the first affected organ in COVID-19. However, sustained"/>
 <result pre="proteinuria and haematuria, which are often observed in patients with" exact="coronavirus disease 2019" post="(COVID-19). Infection of endothelial cells alters glomerular capillary haemostasis"/>
 <result pre="exhibit high levels of ACE2 in the apical brush border." exact="SARS-CoV-2 infection" post="leads to loss of the brush border and vacuolar"/>
 <result pre="the APOL1 â€˜riskâ€™ genotype in inducing focal segmental glomerulosclerosis following" exact="SARS-CoV-2 infection," post="as well as the role of haemodynamic factors, cardiac"/>
 <result pre="targets to prevent kidney dysfunction and/or hasten renal recovery during" exact="SARS-CoV-2 infection." post="Several non-specific mechanisms may contribute to the development of"/>
 <result pre="suggesting that they are potential SARS-CoV-2 targets173,174. ACE2 internalization following" exact="SARS-CoV-2 infection" post="could induce an imbalance in the reninâ€&quot;angiotensinâ€&quot;aldosterone system, with"/>
 <result pre="clotting and systemic microangiopathy. Antiviral therapies The first week following" exact="SARS-CoV-2 infection" post="â€&quot; during which the virus enters alveolar cells and"/>
 <result pre="considered. For example, the observed suppression of interferon responses following" exact="SARS-CoV-2 infection" post="suggests that interferon supplementation may be a potential therapeutic"/>
 <result pre="C3 is required for protection from the highly pathogenic H5N1" exact="influenza infection" post="and proper viral clearance246, suggesting that C3 inhibition may"/>
 <result pre="polyclonal antibodies from convalescent patients. Conclusions Available evidence demonstrates that" exact="SARS-CoV-2 infection" post="induces immune dysfunction, widespread endothelial injury, complement-associated coagulopathy and"/>
 <result pre="diseaseInt. J. Legal Med.2020341271127410.1007/s00414-020-02318-9 26.PernazzaAet al.Early histologic findings of pulmonary" exact="SARS-CoV-2 infection" post="detected in a surgical specimenVirchows Arch.202010.1007/s00428-020-02829-132915266 27.HuangCet al.Clinical features"/>
 <result pre="COVID-19 in Wuhan, ChinaJAMA Cardiol.2020580281010.1001/jamacardio.2020.095032211816 37.ZangRet al.TMPRSS2 and TMPRSS4 promote" exact="SARS-CoV-2 infection" post="of human small intestinal enterocytesSci. Immunol.20205eabc358210.1126/sciimmunol.abc358232404436 38.LamersMMet al.SARS-CoV-2 productively"/>
 <result pre="al.Reduction and functional exhaustion of T cells in patients with" exact="coronavirus disease 2019" post="(COVID-19)Front. Immunol.20201182710.3389/fimmu.2020.0082732425950 75.Chen, Y. et al. The novel severe"/>
 <result pre="et al. Longitudinal evaluation and decline of antibody responses in" exact="SARS-CoV-2 infection." post="Preprint at medRxiv10.1101/2020.07.09.20148429 (2020). 97.IbarrondoFJet al.Rapid decay of anti-SARS-CoV-2"/>
 <result pre="with acute respiratory distress syndrome and death in patients with" exact="coronavirus disease 2019" post="pneumonia in Wuhan, ChinaJAMA Intern. Med.202018011110.1001/jamainternmed.2019.43467070509 209.RussellBet al.Associations between"/>
 <result pre="benefit in COVID-19Lancet Rheumatol.20202e59210.1016/S2665-9913(20)30313-132929415 224.DimopoulosGet al.Favorable anakinra responses in severe" exact="Covid-19" post="patients with secondary hemophagocytic lymphohistiocytosisCell HostMicrobe202028117123.e1 225.AhnEet al.Role of"/>
 <result pre="(2020). 241.YamamotoMet al.Identification of nafamostat as a potent inhibitor of" exact="Middle East respiratory syndrome" post="coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell"/>
</results>
